Rekover Therapeutics is a biotechnology company focused on developing novel therapies for the repair of tissue damage caused by Multiple Sclerosis (MS). Our lead drug candidate is a first-in-class, Phase 2 ready molecule with promising preclinical data in two animal disease models and a strong safet...See more
Headquarters:
New Zealand
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2020 (6 years)
Address:
WELLINGTON, NZ
Employees by Department
- The Rest (1)
- Total (1)
Key Decision Makers
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has REKOVER THERAPEUTICS been operating for?
- What is the funding status of REKOVER THERAPEUTICS?
- Where is REKOVER THERAPEUTICS's headquarter?
- What REKOVER THERAPEUTICS's spending power?
- Does REKOVER THERAPEUTICS have a presence in the domain it operates in?
